Manufacturing / R&D
Products with Highest Quality
Aditri's collaborative manufacturing facilities are state-of-the-art, multipurpose facilities that comply with cGMP standards and meet the requirements of USFDA, EU, and Stringent Regulatory Authorities (SRA).
Manufacturing Infrastructure / R&D Capabilities
State-of-the-art collaborative manufacturing for regulated markets.
Finished Formulator
Steril Gene Life Sciences Pvt Ltd
Steril Gene Life Sciences Pvt Ltd, India has an annual manufacturing capacity of 3 billion tablets and 1 billion capsules.
WHO GenevaUSA FDAUK MHRAEU GMPANVISA (Brazil)DGMEDHealth CanadaTGA AustraliaMTMDA (Tanzania)MCAZ (Zimbabwe)
API Manufacturing Facility
Vinta Labs Pvt Ltd
Vinta Labs Pvt Ltd, India has an annual manufacturing capacity of 150 KL. Manufacturing capabilities include Research & Development. The site has been successfully audited by WHO-PQ recently for Dolutegravir.
150KL Annual CapacityResearch & Development
Compliance Support
BA/BE Partners
BA/BE partners are based in India and are USFDA approved labs.
USFDA Approved LabsIndia-Based Partners
Facility Gallery
Facility photography from API manufacturing ecosystem.
Aditri has been successfully audited by WHO-PQ in July 2026.Aditri holds the Market Authorization (MA) for Finished Dosages and select APIs.Aditri has been successfully audited by WHO-PQ in July 2026.Aditri holds the Market Authorization (MA) for Finished Dosages and select APIs.
✦ API - WHO-PQ✦ Dosages - USFDA✦ WHO-Geneva✦ MHRA✦ SAPHRA✦ EU GMP✦ BA/BE - USFDA✦ MHRA/EU GMP✦ API - WHO-PQ✦ Dosages - USFDA✦ WHO-Geneva✦ MHRA✦ SAPHRA✦ EU GMP✦ BA/BE - USFDA✦ MHRA/EU GMP